Riding the Non-IgG Wave: Why Researchers Are Turning to Alternative Immunoglobulins
For years, the life sciences community has focused its attention—and budgets—on IgG antibodies. They were the gold standard for therapeutic development, biomarker screening, and diagnostic innovation. But as biological questions grow more complex and precision medicine becomes increasingly nuanced, a new trend has emerged: a surge of interest in non-IgG antibodies and proteins....
0 Commentaires 0 Parts 1KB Vue 0 Aperçu
Commandité
Commandité
Commandité
google-site-verification: google037b30823fc02426.html